Chelsea Royal Care Pharm Inc - NY New York, New York City 10011

Chelsea Royal Care Pharm Inc entered the industry of in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.

To acquire more information, please contact Aleksandr Abdurakhmanov, Owner by calling (212) 255-8000 during business hours. You can also write to the business’ Single Location at 154 9th Avenue, New York City, New York NY 10011. You can also visit the company’s website at chelsearoyalcarepharmacy.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Chelsea Royal Care Pharm Inc
Representative: Aleksandr Abdurakhmanov, Owner
Place of Business: 154 9th Avenue, New York City, NY 10011
Contact Number: (212) 255-8000
Website: chelsearoyalcarepharmacy.com
Type of Service:
SIC Number: 5912
NAICS Number: 4461100
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2011
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Chelsea Royal Care Pharm Inc is a company operating from New York, New York providing professional and relevant B2C variables. It was founded in 2011 and registered with the SIC code 5912 as , and with the NAICS code 4461100 as .

With a current employee count of 1 to 4, Chelsea Royal Care Pharm Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Aleksandr Abdurakhmanov, Owner at (212) 255-8000 for related queries, or to locate its Single Location using the coordinates 40.744415,-74.002658.

The Single Location can also be found at the street address 154 9th Avenue in New York City, New York 10011 and can be engaged online through the company website at chelsearoyalcarepharmacy.com, the company Twitter , and Facebook page .